Posts found in:
Brad L. Schoenfeld
Why Emerging Life Science And Pharma Companies Should Apply The CRO Model To Commercial Contracts
- Brad L. Schoenfeld
- |
- February 19, 2019
2019 is off to a fast start in the life science, pharmaceutical and medical device industries with unprecedented market growth. Life sciences, in particular, continue on an upward trend, accounting for nearly 15 percent of venture deal flow in 2018, more than 60 percent of which were deals of $50…
